Related references
Note: Only part of the references are listed.Prostate cancer
Richard J. Rebello et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging
Shane C. Masters et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them
Aleksei E. Machulkin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
Asim Afaq et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection
Longfei Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer
Wojciech G. Lesniak et al.
NANOSCALE (2021)
Prostate-Specific Membrane Antigen-Guided Surgery
Tobias Maurer et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
Meghana Kulkarni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer
Margret Schottelius et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting
Daniele Vinciguerra et al.
BIOMACROMOLECULES (2019)
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
Thomas Van den Broeck et al.
EUROPEAN UROLOGY (2019)
PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery
Yvonne H. W. Derks et al.
THERANOSTICS (2019)
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG
Zhantong Wang et al.
BIOCONJUGATE CHEMISTRY (2018)
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
Thorsten Derlin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Imaging Characteristics and First Experience of [68Ga]THP-PSMA, a Novel Probe for Rapid Kit-Based Ga-68 Labeling and PET Imaging: Comparative Analysis with [68Ga]PSMA I&T
Thorsten Derlin et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
In vivo near infrared fluorescence imaging and dynamic quantification of pancreatic metastatic tumors using folic acid conjugated biodegradable mesoporous silica nanoparticles
Hanrui Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Hydroxypyridinone Journey into Metal Chelation
Agostino Cilibrizzi et al.
CHEMICAL REVIEWS (2018)
68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling
Jennifer D. Young et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Improving the Imaging Contrast of 68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties
Ann-Christin Baranski et al.
BIOCONJUGATE CHEMISTRY (2017)
Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging
Takao Yogo et al.
BIOCONJUGATE CHEMISTRY (2017)
PSMA-targeted contrast agents for intraoperative imaging of prostate cancer
Kai Bao et al.
CHEMICAL COMMUNICATIONS (2017)
Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants
Stacey Markovic et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
Ana P. Kiess et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field
Xiaomin Yi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer
Xinning Wang et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
Florian Kampmeier et al.
EJNMMI RESEARCH (2014)
Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies
Ahu Yuan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Image-guided cancer surgery using near-infrared fluorescence
Alexander L. Vahrmeijer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Bispecific small molecule-antibody conjugate targeting prostate cancer
Chan Hyuk Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cationic Nanohydrogel Particles as Potential siRNA Carriers for Cellular Delivery
Lutz Nuhn et al.
ACS NANO (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen
Ying Chen et al.
BIOCONJUGATE CHEMISTRY (2012)
Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme
J. Pavlicek et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Novel Phosphate Derivatives as Scaffolds for the Preparation of Synthetic Phosphoserine-Based Peptides Using the Fmoc/t-Bu Solid-Phase Strategy
Agostino Cilibrizzi et al.
SYNLETT (2012)
A facile surfactant critical micelle concentration determination
Lifeng Cai et al.
CHEMICAL COMMUNICATIONS (2011)
Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)
Sachin S. Chandran et al.
CANCER BIOLOGY & THERAPY (2010)
A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules
Andrew X. Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality
Jonathan L. Wright et al.
JOURNAL OF UROLOGY (2010)
A low molecular weight PSMA-based fluorescent imaging agent for cancer
Ying Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
K. P. Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization
Cyril Barinka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
JR Mesters et al.
EMBO JOURNAL (2006)
NAAG peptidase inhibitors and their potential for diagnosis and therapy
J Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Share Paper
